If you're interested in shaping the future of Western medicine by improving the quality of life for. Dantonic is a modernized and industrialized botanical drug formula of Danshen (Radix Salviae Miltiorrhizae, RSM) and Sanqi (Radix Notoginseng, RN) as active ingredients and Borneol as absorption enhancer. Dantonic was approved as a prescription drug for the treatment of chronic stable angina pectoris in patients with coronary heart disease by the State Food and Drug Administration of China (CFDA) in 1993.
Services
Tasly Pharmaceuticals, Inc. (TaslyUS), was founded in 2006 and is based in Rockville, Maryland. At Tasly, our vision is to change the way the world takes and understands medicine. Through decades of research and development, we are geared to become a world-renowned innovator in pharmaceuticals, biologics, and nutraceuticals.
Tasly US' mission is "Dedicated to a Healthier World", to provide an effective, safe, and high-quality plant-based alternative solution to the medical community and patients. We believe the world is ready for a holistic approach to medicine and through Innovative Herbal Medicine (IHM). We at Tasly can offer such an approach.
Tasly prides itself as an example of global diversity. Employees enjoy a culture-rich environment, with a focus on celebrating, sharing, and using that diversity to create a productive and inclusive workplace. Tasly believes in providing benefits for the whole person and its benefits and work environment reflect this belief.
Hepatitis B is a major global disease and is called "the national disease" in China for its high incidence rate. Existing drugs can only play an effective role in inhibiting the virus, but virus replication may be active again after drug withdrawal and the disease will relapse, so antiviral treatment needs to be used for a long time.
Cancer immunotherapy is an innovative method of stimulating the immune system in order to kill cancer cells. Cancer cells are able to evade the immune system by the help of a surface molecule called PD-L1, which can bind to the PD-1 and B7-1 on immune cells preventing elimination. Antibodies targeting the PD-1 or PD-L1 have been approved by the US FDA for first- and second-line treatment of certain types of cancer.
Reviews
Be the first to review Tasly Pharmaceuticals.
Write a Review
